Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-090822
Filing Date
2024-08-05
Accepted
2024-08-05 16:29:53
Documents
1
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9168
  Complete submission text file 0000950170-24-090822.txt   10771
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address
Tregoning Kathleen (Reporting) CIK: 0001830764 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39311 | Film No.: 241175211